BOSTON SCIENTIFIC CORPORATION MARLBOROUGH, Mass., Jan. 4, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022. Mike Mahoney, chairman and chief executive officer, will present at 8:15 a.m. EST. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, in a question-and-answer session with the host analyst.
On Wednesday February 2, 2022 Boston Scientific will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2021. The call will begin at 8:00 a.m. EST, hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on February 2 prior to the conference call.
A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.com. The replay will be available approximately one hour following the completion of each event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS | |
Media: | Investors: |
Kate Haranis | Lauren Tengler |
508-683-6585 (office) | 508-683-4479 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
Kate.Haranis@bsci.com | BSXInvestorRelations@bsci.com |
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-jp-morgan-healthcare-conference-and-announces-conference-call-discussing-fourth-quarter-2021-results-301452818.html
SOURCE Boston Scientific Corporation
